英诺特: 北京英诺特生物技术股份有限公司章程(2025年8月修订)

Core Points - The company, Innovita Biological Technology Co., Ltd., was established as a joint-stock limited company in accordance with the Company Law of the People's Republic of China and other relevant regulations [1][2] - The company was approved for public offering of 34.02 million shares and listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 28, 2022 [1][2] - The registered capital of the company is RMB 136.458196 million [2] Company Structure and Governance - The company is a permanent joint-stock limited company, with the general manager serving as the legal representative [2][3] - The legal representative is responsible for civil activities conducted in the company's name, and the company bears civil liability for actions taken by the legal representative [2][3] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with all its assets [2][3] Business Objectives and Scope - The company's mission is to ensure accessible testing and promote health, with core values of customer first, professional innovation, pragmatic efforts, and team collaboration [4] - The business scope includes technology services, import and export of goods, leasing of non-residential real estate, and sales of medical devices among other activities [4] Share Issuance and Capital Management - The company's shares are issued in the form of stocks, with each share having a par value of RMB 1 [4][6] - The company can increase capital through various methods, including issuing shares to unspecified or specific targets, distributing bonus shares, or converting reserves into capital [7] - The company is prohibited from repurchasing its own shares except under specific circumstances, such as capital reduction or mergers [7][8] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, supervision of company operations, and access to company documents [12][13] - Shareholders must comply with laws and the company's articles of association, and they cannot withdraw their capital except as legally permitted [16][40] - Shareholders who abuse their rights causing damage to the company or other shareholders may be held liable for compensation [16] Board and Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [24][25] - The board of directors is responsible for convening shareholder meetings and must ensure compliance with legal and regulatory requirements [54][56] - Shareholders holding more than 10% of shares can request the board to convene a temporary meeting under certain conditions [57][58]